Home > PB Ratio > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of BAFNA PHARMACEUTICALS is 2.37.

Share Price ₹81.0Jan 14,2025
Market Cap ₹192.0 Cr
Book Value₹80.8 CrMar2024 - Standalone Results
Price/Book 2.37xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of BAFNA PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of BAFNA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹192.0 Cr] as on Jan 14,2025

(/) Book Value [ ₹80.8 Cr] based on Mar2024 - Standalone Results

(=) P/B Ratio [ 2.37x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '2.37 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BAFNA PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of BAFNA PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of BAFNA PHARMACEUTICALS


PB Ratio Performance Analysis for BAFNA PHARMACEUTICALS

- BAFNA PHARMACEUTICALS 's latest p/b ratio is 2.37x.

- BAFNA PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.00x.

- BAFNA PHARMACEUTICALS 's operated at median p/b ratio of 2.66x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/b ratio peaked in Mar2021 at 5.72x.

- BAFNA PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of -0.48x.


How does BAFNA PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
BAFNA PHARMACEUTICALS 80.842.37192.0
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.67424,382.0
CIPLA LTD26,619.904.39116,943.0
DR REDDYS LABORATORIES LTD28,123.503.97111,588.0
ZYDUS LIFESCIENCES LTD19,829.505.08100,704.0
DIVIS LABORATORIES LTD13,571.0011.73159,224.0
MANKIND PHARMA LTD9,339.8411.80110,215.0
TORRENT PHARMACEUTICALS LTD6,856.1516.06110,142.0
LUPIN LTD14,175.806.9498,330.0
AUROBINDO PHARMA LTD29,842.802.2968,238.4
ABBOTT INDIA LTD3,658.7316.4160,041.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BAFNA PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.29x
Max industry PB 16.41x
Median industry PB 6.67x
Average industry PB 7.97x



You may also like the below Video Courses